Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

CR ORTOLAB ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   2.2% 2.2% 2.2% 2.2% 2.2% 2.2% 2.2% 2.2%   Bankruptcy risk   9.5% 6.9% 6.8% 4.9% 4.1% 4.6% 11.3% 11.3%   Credit score (0-100)   27 35 34 44 48 46 21 21   Credit rating   BB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,129 815 908 1,182 1,379 1,731 0.0 0.0   EBITDA   405 102 62.2 331 259 523 0.0 0.0   EBIT   399 84.7 29.5 297 227 489 0.0 0.0   Pre-tax profit (PTP)   398.6 86.6 27.3 293.6 218.6 481.0 0.0 0.0   Net earnings   306.7 65.8 23.2 225.1 167.8 374.3 0.0 0.0   Pre-tax profit without non-rec. items   399 86.6 27.3 294 219 481 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   5.4 22.9 106 71.5 93.1 59.2 0.0 0.0   Shareholders equity total   401 267 190 415 333 558 463 463   Interest-bearing liabilities   0.0 23.8 46.9 54.9 133 55.9 0.0 0.0   Balance sheet total (assets)   586 439 338 638 668 855 463 463   Net Debt   -370 -231 4.5 -198 -96.3 -408 -463 -463     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,129 815 908 1,182 1,379 1,731 0.0 0.0   Gross profit growth   40.5% -27.8% 11.4% 30.2% 16.6% 25.5% -100.0% 0.0%   Employees   1 3 2 1 3 2 0 0   Employee growth %   0.0% 200.0% -33.3% -50.0% 200.0% -33.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   586 439 338 638 668 855 463 463   Balance sheet change%   123.4% -25.1% -23.0% 88.8% 4.6% 28.1% -45.8% 0.0%   Added value   405.2 101.6 62.2 331.3 261.7 522.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -13 1 51 -69 -11 -68 -59 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   35.3% 10.4% 3.2% 25.1% 16.5% 28.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   94.0% 16.9% 7.6% 60.8% 34.8% 64.2% 0.0% 0.0%   ROI %   133.8% 25.1% 11.2% 83.8% 48.5% 90.5% 0.0% 0.0%   ROE %   102.9% 19.7% 10.2% 74.3% 44.8% 84.0% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   68.5% 60.8% 56.3% 65.1% 49.9% 65.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -91.3% -227.4% 7.2% -59.6% -37.1% -78.2% 0.0% 0.0%   Gearing %   0.0% 8.9% 24.6% 13.2% 39.8% 10.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 2.2% 6.1% 6.0% 9.0% 8.1% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   2.9 2.1 1.0 1.9 1.3 2.1 0.0 0.0   Current Ratio   3.1 2.4 1.6 2.5 1.7 2.7 0.0 0.0   Cash and cash equivalent   369.8 254.8 42.4 252.5 228.9 464.4 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   396.0 244.3 84.3 344.0 240.2 498.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   405 34 31 331 87 261 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   405 34 31 331 86 261 0 0   EBIT / employee   399 28 15 297 76 244 0 0   Net earnings / employee   307 22 12 225 56 187 0 0